Best Hospital Award

Among the Best in the US

US News and World Report top 50 Cancer Hospital, 2016-2017

Learn More
thyroid cancer ultrasound

Study Informs Long-Term Disease Risks for Thyroid Cancer Survivors

Abstract by HCI trainee featured at 2017 American Society of Clinical Oncology (ASCO) Cancer Survivorship Symposium 

Learn More
HPV Vaccine

New Recommendations for Cancer Prevention:

HCI Joins Nation's Cancer Centers in Endorsing Updated HPV Vaccination Guidelines

Learn More
Radon Awareness

January is National Radon Action Month:

Learn what you can do to manage your exposure to the second-leading cause of lung cancer

Learn More

The Only Cancer Institute in the World Designed by a Patient

Jon Huntsman, Sr., has had cancer four times. So he’s spent enough time in cancer hospitals to know what he’d do differently when he designed one from scratch. That’s why Huntsman Cancer Institute is unlike any other. It looks different. Feels different.

In The Media, HCI News

Using the Patient’s Immune System to Treat One of the Deadliest Cancers

Pancreatic cancer is a deadly disease that presents unique challenges for researchers. Clinical trials at Huntsman Cancer Institute (HCI) are testing immunotherapy, medicines that stimulate the patient’s immune system, to boost the effects of standard chemotherapy drugs in treating pancreatic cancer.

Read More

In The Media, HCI News

Positive Side Effects: Your New Year’s Resolutions Could Reduce Your Cancer Risk

For many of us, 2017’s New Year’s resolutions echo past resolutions we didn’t quite manage to keep. If your goals for 2017 include exercising more, eating better and cutting back on smoking or drinking, the experts at Huntsman Cancer Institute have some information that could help inspire success: these changes are also an integral part of protecting yourself against cancer.

Read More

In The Media, HCI News

Enough is Enough: Choosing the Right Treatment for Thyroid Cancer

When it comes to treating thyroid cancer, less can be more. The adage certainly proved true for Lisa Anderson. After the mother of one was diagnosed with papillary thyroid cancer, doctors at Huntsman Cancer Institute assessed her risk to decide which treatment would be most effective for her.

Read More

In The Media, HCI News

Holidays are Family Time: To Stay Healthy, Talk More than Turkey

Sara learned she had a rare form of gastrointestinal cancer at the age of 37. She told her family and just a few weeks later, her brother had a check-up. His doctors found he had stage 4 colon cancer. Surprised and shaken by the coinciding diagnoses, Sara and her family turned to Samantha Greenberg, a genetic counselor at Huntsman Cancer Institute for answers.

Read More

Recent News

Press Releases, In The Media

Huntsman Cancer Institute Research Holds Promise for Personalized Lung Cancer Treatments

New research from scientists at Huntsman Cancer Institute (HCI) at the University of Utah uncovered distinct types of tumors within small cell lung cancer that look and act differently from one another. Scientists also identified a targeted drug combination that worked well with one specific tumor type. The study was published today in Cancer Cell. The findings suggest small cell lung cancer should not be treated as a uniform disease

Read More

Press Releases, In The Media

Huntsman Cancer Institute Joins Nation’s Cancer Centers to Endorse Updated HPV Vaccine Recommendations

Recognizing a critical need to improve national vaccination rates for human papillomavirus (HPV), Huntsman Cancer Institute (HCI) at the University of Utah has united with each of the 69 National Cancer Institute (NCI)-designated cancer centers in support of recently revised recommendations from the Centers for Disease Control and Prevention (CDC).

Read More

In The Media, HCI News

Using the Patient’s Immune System to Treat One of the Deadliest Cancers

Pancreatic cancer is a deadly disease that presents unique challenges for researchers. Clinical trials at Huntsman Cancer Institute (HCI) are testing immunotherapy, medicines that stimulate the patient’s immune system, to boost the effects of standard chemotherapy drugs in treating pancreatic cancer.

Read More